Work

Systemic and CNS activity of the RET inhibitor vandetanib combined with the mTOR inhibitor everolimus in KIF5B-RET re-arranged non-small cell lung cancer with brain metastases

Year: 2015

Type: article

Source: Lung Cancer

DOI: 10.1016/j.lungcan.2015.04.004

Authors: Vivek Subbiah, Jenny Berry, Michael Roxas, Nandita Guha-Thakurta, Ishwaria Mohan Subbiah, Siraj M. Ali, Caitlin McMahon, Vincent Miller, Tina Cascone, Shobha Pai, Zhenya Tang, John V. Heymach

Institutions: The University of Texas MD Anderson Cancer Center, Foundation Medicine (United States)

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, University of Texas MD Anderson Cancer Center, National Cancer Institute

Awards: G111615301, G1468253849, G1901027039, Cancer Center Support Grant

OpenAlex ID: W2067026376

FWCI: 6.891

Cites: 29

Cited by: 68

Related to: 10